endometrial cancer health outcomes: pembrolizumab for patients with msi-high endometrial cancer
Published 2 years ago • 691 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
0:56
mirvetuximab soravtansine with pembrolizumab in mss endometrial cancer
-
2:51
molecular classification and adjuvant treatment in endometrial cancer
-
1:00
precision oncology in endometrial cancer
-
3:28
keynote-775 subgroup analysis in advanced endometrial cancer
-
1:22
dr. zamarin on the role of pembrolizumab in endometrial cancer
-
5:23
latest developments in immunotherapy for advanced/recurrent endometrial cancer
-
1:36
what are the benefits of including chemotherapy in the treatment of endometrial cancer?
-
8:20
immune checkpoint inhibitors for endometrial and cervical cancer
-
2:56
keynote-177: final pfs analysis of pembrolizumab in patients with msi-h/dmmr mcrc
-
1:22
msi as a biomarker in gynecological cancer
-
0:47
endometrial cancer | 3d
-
1:21
how different factors affect treatment of endometrial cancer
-
57:40
immunotherapy in endometrial cancer: expanding horizons
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
6:07
evolving medical treatment in advanced/recurrent endometrial cancer
-
1:22
dr. hensley on dmrr and msi-h testing in endometrial cancer
-
36:22
modern, molecularly informed therapy for patients with advanced endometrial cancer
-
0:47
dr. levine on immunotherapy in endometrial cancer
-
4:08
updates in testing endometrial cancer biomarkers